These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 31183637)

  • 1. Biomarkers in heart failure: the past, current and future.
    Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
    Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel heart failure biomarkers: why do we fail to exploit their potential?
    Piek A; Du W; de Boer RA; Silljé HHW
    Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
    Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
    Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
    Gruson D; Ahn SA; Rousseau MF
    Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The involvement of galectin-3 in heart failure].
    Kałan M; Witczak A; Mosiewicz J; Donica H
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1107-13. PubMed ID: 26400896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
    Garg A; Virmani D; Agrawal S; Agarwal C; Sharma A; Stefanini G; Kostis JB
    Cardiology; 2017; 136(3):192-203. PubMed ID: 27784010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
    Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for the diagnosis and management of heart failure.
    Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M
    Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure].
    Lakomkin SV; Skvortsov AA; Goriunova TV; Masenko VP; Tereshchenko SN
    Kardiologiia; 2012; 52(3):45-52. PubMed ID: 22839443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biomarkers for the diagnosis and management of heart failure: new frontiers].
    Vergaro G; Castiglione V; Aimo A; Prontera C; Musetti V; Masotti S; Giannelli E; Maltinti M; Passino C; Emdin M
    G Ital Cardiol (Rome); 2021 May; 22(5):386-396. PubMed ID: 33960982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current and Potential Clinical Relevance of Heart Failure Biomarkers.
    Gandhi PU; Testani JM; Ahmad T
    Curr Heart Fail Rep; 2015 Oct; 12(5):318-27. PubMed ID: 26280466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes.
    Yang EY; Khan MA; Graviss EA; Nguyen DT; Bhimaraj A; Nambi V; Hoogeveen RC; Ballantyne CM; Zoghbi WA; Shah DJ
    Sci Rep; 2019 Dec; 9(1):20168. PubMed ID: 31882822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers and heart disease.
    Sun RR; Lu L; Liu M; Cao Y; Li XC; Liu H; Wang J; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2927-35. PubMed ID: 25339488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
    Meijers WC; de Boer RA; van Veldhuisen DJ; Jaarsma T; Hillege HL; Maisel AS; Di Somma S; Voors AA; Peacock WF
    Eur J Heart Fail; 2015 Dec; 17(12):1271-82. PubMed ID: 26466857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.